Search
for
Sort by
Research 30 of 1000+
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Skin toxicity of anti‐cancer therapy
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
- Novel Therapeutic Hybrid Systems Using Hydrogels and Nanotechnology: A Focus on Nanoemulgels for the Treatment of Skin Diseases
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Cosmeceutical Therapy: Engaging the Repercussions of UVR Photoaging on the Skin’s Circadian Rhythm
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Melanocyte stem cells in the skin: Origin, biological characteristics, homeostatic maintenance and therapeutic potential
- Skin Manifestations of Targeted Antineoplastic Therapy
- Correction: RASopathic Skin Eruptions during Vemurafenib Therapy
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Cutaneous toxicities of cancer therapy
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Rosmarinus officinalis and Skin: Antioxidant Activity and Possible Therapeutical Role in Cutaneous Diseases
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer
- Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells
- Non-surgical treatments for basal cell skin cancer
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Simple and Selective HPLC-UV/Vis Bioanalytical Method to Determine Aluminum Phthalocyanine Chloride in Skin Permeation Studies
- The Circadian Clock in Skin
- Effect of estrogens on skin aging and the potential role of SERMs
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- The Comparison of In Vitro Photosensitizing Efficacy of Curcumin-Loaded Liposomes Following Photodynamic Therapy on Melanoma MUG-Mel2, Squamous Cell Carcinoma SCC-25, and Normal Keratinocyte HaCaT Cells
- Artificial Pigmented Human Skin Created by Muse Cells